Disclosed is the use of a therapeutically effective amount of one or more compounds for the manufacture of a medicament for nephroprotection in a patient with impaired kidney function associated with renal fibrosis and said compounds are described by formula I or formula II or a combination thereof wherein the substituents are defined in the specification.